Related Experiment Videos
Crystallization and preliminary X-ray diffraction analysis of human phosphate-binding protein
Carlos Contreras-Martel1, Philippe Carpentier, Renaud Morales
1Laboratoire de Cristallogenèse et Cristallographie des Protéines, Institut de Biologie Structurale J.-P. Ebel, 38027 Grenoble, France.
Summary
Human phosphate-binding protein (HPBP), a novel plasma transporter, was discovered. This protein may predict and treat phosphate-related diseases like atherosclerosis.
Area of Science:
- Biochemistry
- Structural Biology
- Molecular Medicine
Background:
- Human phosphate-binding protein (HPBP) is a 38 kDa apoprotein.
- HPBP belongs to the eukaryotic DING protein family, absent from genomic databases.
- HPBP copurifies with HDL-associated paraoxonase (PON1) and binds inorganic phosphate.
Purpose of the Study:
- To report the purification, detergent-exchange protocol, and crystallization conditions for HPBP.
- To introduce HPBP as the first identified phosphate-binding transporter in human plasma.
- To explore HPBP's potential as a predictor and therapeutic target for phosphate-related diseases.
Main Methods:
- Crystallization and X-ray crystallography were employed for HPBP discovery.
- Purification protocols and a detergent-exchange method were developed.
- Crystallization conditions were optimized.
Main Results:
- HPBP was serendipitously discovered through structural analysis.
- The study details the methods enabling HPBP isolation and characterization.
- HPBP's ability to bind inorganic phosphate was confirmed.
Conclusions:
- HPBP represents a significant discovery in human plasma protein research.
- Its role as a phosphate transporter suggests implications for atherosclerosis and related diseases.
- HPBP holds potential for diagnostic and therapeutic applications in managing phosphate homeostasis.